Normal view MARC view ISBD view

The application of a model T Coulter Counter to dissolution rate studies. [electronic resource]

By:

Marshall, K

Contributor(s):

Meaking, B C

Producer: 19730629Description: Suppl:151P-152 p. digitalISSN:

0022-3573

Subject(s):

In: The Journal of pharmacy and pharmacology vol. 24

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

121 High early mortality rate in elderly patients with multiple myeloma receiving a vincristine-doxorubicin-dexamethasone regimen.
by Teng, Hao-Wei
122 Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial.
by Chung, Chih-Yuan
123 Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B.
by Wu, Chia-Yun
124 Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
by Liu, Yao-Chung
125 Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
by Chen, Po-Min
126 Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.
by Wang, Hao-Yuan
127 Nardilysin Is Required for Maintaining Pancreatic β-Cell Function.
by Nishi, Kiyoto
128 Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.
by Hsiao, Liang-Tsai
129 International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.
by Yang, Sheng-Hsiang
130 Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.
by Huang, Yu-Chung
131 A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
by Liu, Chia-Jen
132 Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma.
by Lin, Chia-Hsin
133 A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system.
by Yu, Yuan-Bin
134 Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
by Huang, Yu-Chung
135 Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.
by Yen, Chueh-Chuan
136 Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma.
by Wong, Fen-Hwa
137 High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.
by Chen, Po-Min
138 Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus.
by Hiwasa, Takaki
139 Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.
by Yen, Chueh-Chuan
140 Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
by Yamashita, Yugo